TRxADE HEALTH, Inc. completed its merger with Superlatus, Inc., acquiring 19.9% of the total issued and outstanding common stock of the Company and 306,855 shares of Series B Preferred Stock.
AI Assistant
SCIENTURE HOLDINGS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.